Yi-Jong Lin

General Counsel at TaiGen Biotechnology Co., Ltd.

Health Technology

Consumer Non-Durables

Consumer Services

Profile

Yi-Jong Lin is a professional who currently holds the position of Vice President-Regulatory Affairs at TaiGen Biotechnology Co., Ltd.
Prior to this, he worked as a Principal at Colgate-Palmolive Co. and Eisai Medical Research, Inc. Dr. Lin received his graduate and doctorate degrees from the University of Tokyo.

Yi-Jong Lin active positions

Companies	Position	Start
TaiGen Biotechnology Co., Ltd. TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan.	General Counsel	2010-01-10

All active positions of Yi-Jong Lin

Former positions of Yi-Jong Lin

Companies	Position	End
COLGATE-PALMOLIVE COMPANY	Corporate Officer/Principal	-
Eisai Medical Research, Inc.	Corporate Officer/Principal	-

See the detail of Yi-Jong Lin's experience

Training of Yi-Jong Lin

University of Tokyo

Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Yi-Jong Lin's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
COLGATE-PALMOLIVE COMPANY	Consumer Non-Durables

Private companies	2
TaiGen Biotechnology Co., Ltd. TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan.	Health Technology
Eisai Medical Research, Inc.